Millipore Sigma Vibrant Logo

217696 Cdk1 Inhibitor, CGP74514A - CAS 190654-01-4 - Calbiochem

The Cdk1 Inhibitor, CGP74514A, also referenced under CAS 190654-01-4, controls the biological activity of Cdk1. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: CGP74514A, N-(cis-2-Aminocyclohexyl)-N-(3-chlorophenyl)-9-ethyl-9H-purine-2,6-diamine

Primary Target: Cdk1/cyclin B
217696
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
190654-01-4C₁₉H₂₄ClN₇

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
217696-5MG
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Fiala di plastica 5 mg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewA cell-permeable and ATP competitive 2,6,9-substituted purine derivative that acts as a potent, selective inhibitor of Cdk1/cyclin B (IC50 = 25 nM). Reported to affect the activities of other kinases only at much higher concentrations (IC50 = 6.1 µM, 125 µM, and > 10 µM for PKCα, PKA, and EGFR, respectively). Shown to induce mitochondrial damage and apoptosis (≥ 3 µM) in several human leukemia cell lines. At lower concentrations (~1 µM), an initial G2M cell cycle arrest was observed in U937 cells, which eventually lead to apoptosis.
      Catalogue Number217696
      Brand Family Calbiochem®
      SynonymsCGP74514A, N-(cis-2-Aminocyclohexyl)-N-(3-chlorophenyl)-9-ethyl-9H-purine-2,6-diamine
      References
      ReferencesYu. C., et al. 2003. Cancer Res. 63, 1822.
      Dai, Y., et al. 2002. Cell Cycle 1, 143.
      Imbach, P., et al. 1999. Bioorg. Med. Chem. Lett. 9, 91.
      Product Information
      CAS number190654-01-4
      ATP CompetitiveY
      DeclarationSold under license from Novartis Pharma AG.
      FormOff-white solid
      Hill FormulaC₁₉H₂₄ClN₇
      Chemical formulaC₁₉H₂₄ClN₇
      ReversibleN
      Structure formula ImageStructure formula Image
      Applications
      Biological Information
      Primary TargetCdk1/cyclin B
      Primary Target IC<sub>50</sub>25 nM against Cdk1/cyclin B
      Purity≥ 95% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Irritant
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution aliquot and freeze(-20°C). Stock solutions are stable for up to 3 months at -20°C
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      217696-5MG 04055977202328

      Documentation

      Cdk1 Inhibitor, CGP74514A - CAS 190654-01-4 - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      217696

      Riferimenti bibliografici

      Panoramica delle referenze
      Yu. C., et al. 2003. Cancer Res. 63, 1822.
      Dai, Y., et al. 2002. Cell Cycle 1, 143.
      Imbach, P., et al. 1999. Bioorg. Med. Chem. Lett. 9, 91.
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision16-December-2009 RFH
      SynonymsCGP74514A, N-(cis-2-Aminocyclohexyl)-N-(3-chlorophenyl)-9-ethyl-9H-purine-2,6-diamine
      DescriptionA cell-permeable, potent, reversible, ATP-competitive and selective inhibitor of Cdk1/cyclin B (IC50 = 25 nM). Affects the activities of other kinases only at higher concentrations (IC50 = 6.1 µM for PKCα, 125 µM for PKA, and >10 µM for EGFR). Also reported to induce mitochondrial damage and apoptosis in several human leukemia cell lines (>3 µM). At lower concentrations (~1 µM) an initial G2M cell cycle arrest and eventual apoptosis has been reported to occur in U937 cells.
      FormOff-white solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number190654-01-4
      Chemical formulaC₁₉H₂₄ClN₇
      Structure formulaStructure formula
      Purity≥ 95% by HPLC
      SolubilityDMSO (10 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution aliquot and freeze(-20°C). Stock solutions are stable for up to 3 months at -20°C
      Toxicity Irritant
      ReferencesYu. C., et al. 2003. Cancer Res. 63, 1822.
      Dai, Y., et al. 2002. Cell Cycle 1, 143.
      Imbach, P., et al. 1999. Bioorg. Med. Chem. Lett. 9, 91.